Axsome Therapeutics Ownership 2024 | Who Owns Axsome Therapeutics Now?
Institutional Ownership
85.79%
Insider Ownership
16.84%
Retail Ownership
-2.63%
Institutional Holders
267.00
Axsome Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.78% | 5.78% | 4,634,331 | 141,652 | 3.15% | 373,063,646 | Jun 30, 2024 |
| VANGUARD GROUP INC | 7.90% | 0.01% | 3,742,002 | 1,724 | 0.05% | 301,231,161 | Jun 30, 2024 |
| BLACKROCK INC. | 6.96% | 0.01% | 3,299,991 | 104,501 | 3.27% | 265,649,278 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 4.98% | 21.46% | 2,360,077 | - | - | 189,986,199 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 3.91% | 4.45% | 1,852,784 | 548,063 | 42.01% | 149,149,112 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 2.26% | 0.10% | 1,073,242 | 372,832 | 53.23% | 86,396,000 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 2.11% | 1.06% | 1,000,000 | - | - | 80,500,000 | Jun 30, 2024 |
| BVF INC/IL | 2.02% | 2.15% | 955,000 | 955,000 | 100.00% | 76,877,500 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.98% | 1.29% | 938,714 | 592,002 | 170.75% | 75,566,477 | Jun 30, 2024 |
| STATE STREET CORP | 1.98% | 0.00% | 938,503 | -213 | -0.02% | 75,549,492,000 | Jun 30, 2024 |
| FMR LLC | 1.90% | 0.00% | 902,136 | 73,586 | 8.88% | 72,621,936 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.88% | 0.01% | 890,985 | 705,272 | 379.76% | 71,724,294 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.87% | 0.01% | 884,895 | 39,488 | 4.67% | 71,248,564 | Jun 30, 2024 |
| ALETHEA CAPITAL MANAGEMENT, LLC | 1.56% | 45.25% | 740,888 | 97 | 0.01% | 59,641,484 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.56% | 0.03% | 739,819 | -1,699 | -0.23% | 59,555,430 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.55% | 0.01% | 734,620 | 57,974 | 8.57% | 59,136,912 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.54% | 0.11% | 730,000 | 215,000 | 41.75% | 58,765,000 | Jun 30, 2024 |
| INVESCO LTD. | 1.18% | 0.01% | 557,861 | 312,208 | 127.09% | 44,907,813 | Jun 30, 2024 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 1.16% | 0.92% | 549,066 | 28,316 | 5.44% | 44,199,813 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 1.09% | 0.68% | 516,533 | -168,943 | -24.65% | 41,580,907 | Jun 30, 2024 |
Axsome Therapeutics's largest institutional shareholder is RTW INVESTMENTS, LP, holding 9.78% of the company's total share outstanding, currently valued at $373.06M. The top 10 institutional shareholders own together 43.88% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1.56% | 45.25% | 740,888 | 97 | 0.01% | 59,641,484 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 4.98% | 21.46% | 2,360,077 | - | - | 189,986,199 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.61% | 14.11% | 290,772 | 158,335 | 119.56% | 23,407,146 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.65% | 6.24% | 306,513 | 203,802 | 198.42% | 24,674,297 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.78% | 5.78% | 4,634,331 | 141,652 | 3.15% | 373,063,646 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 3.91% | 4.45% | 1,852,784 | 548,063 | 42.01% | 149,149,112 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.71% | 4.42% | 337,246 | -4,927 | -1.44% | 27,148,303 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.32% | 3.78% | 150,000 | -60,000 | -28.57% | 12,075,000 | Jun 30, 2024 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 0.27% | 2.31% | 126,905 | -1,937 | -1.50% | 10,215,853 | Jun 30, 2024 |
| BVF INC/IL | 2.02% | 2.15% | 955,000 | 955,000 | 100.00% | 76,877,500 | Jun 30, 2024 |
| SVB FINANCIAL GROUP | 0.07% | 1.91% | 33,849 | - | - | 2,724,845 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 0.99% | 1.86% | 467,427 | - | - | 37,627,874 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.84% | 1.86% | 400,000 | 400,000 | 100.00% | 32,200,000 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.13% | 1.83% | 62,192 | 13,665 | 28.16% | 5,006,456 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.63% | 1.80% | 300,000 | 300,000 | 100.00% | 24,150,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.84% | 1.70% | 400,000 | - | - | 32,200,000 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.28% | 1.66% | 132,312 | 18,185 | 15.93% | 10,651,116 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.11% | 1.64% | 50,000 | -88,000 | -63.77% | 4,025,000 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.16% | 1.50% | 74,332 | -7,700 | -9.39% | 5,867,025 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.19% | 1.37% | 87,848 | - | - | 7,071,764 | Jun 30, 2024 |
The largest Axsome Therapeutics shareholder by % of total assets is ALETHEA CAPITAL MANAGEMENT, LLC. The company owns 740.89K shares of Axsome Therapeutics (AXSM), representing 45.25% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 2.02% | 2.15% | 955,000 | 955,000 | 100.00% | 76,877,500 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.88% | 0.01% | 890,985 | 705,272 | 379.76% | 71,724,294 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.98% | 1.29% | 938,714 | 592,002 | 170.75% | 75,566,477 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 3.91% | 4.45% | 1,852,784 | 548,063 | 42.01% | 149,149,112 | Jun 30, 2024 |
| NORGES BANK | 0.85% | 0.00% | 404,217 | 404,217 | 100.00% | 32,539,469 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.84% | 1.86% | 400,000 | 400,000 | 100.00% | 32,200,000 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 2.26% | 0.10% | 1,073,242 | 372,832 | 53.23% | 86,396,000 | Jun 30, 2024 |
| INVESCO LTD. | 1.18% | 0.01% | 557,861 | 312,208 | 127.09% | 44,907,813 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.65% | 1.30% | 310,198 | 310,198 | 100.00% | 24,970,939 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.63% | 1.80% | 300,000 | 300,000 | 100.00% | 24,150,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.54% | 0.11% | 730,000 | 215,000 | 41.75% | 58,765,000 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 0.65% | 6.24% | 306,513 | 203,802 | 198.42% | 24,674,297 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.61% | 14.11% | 290,772 | 158,335 | 119.56% | 23,407,146 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.78% | 5.78% | 4,634,331 | 141,652 | 3.15% | 373,063,646 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.85% | 0.01% | 401,327 | 109,715 | 37.62% | 32,306,824 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.29% | 0.00% | 135,855 | 108,813 | 402.39% | 10,936,325 | Jun 30, 2024 |
| BLACKROCK INC. | 6.96% | 0.01% | 3,299,991 | 104,501 | 3.27% | 265,649,278 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.01% | 0.10% | 479,044 | 100,180 | 26.44% | 38,563,069 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.36% | 0.00% | 168,762 | 88,608 | 110.55% | 13,585,341 | Jun 30, 2024 |
| FMR LLC | 1.90% | 0.00% | 902,136 | 73,586 | 8.88% | 72,621,936 | Jun 30, 2024 |
As of Jun 30 2024, Axsome Therapeutics's largest institutional buyer is BVF INC/IL. The company purchased 955.00K stocks of AXSM, valued at $76.88M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 0.97% | 0.88% | 459,111 | -646,230 | -58.46% | 36,958,436 | Jun 30, 2024 |
| MORGAN STANLEY | 0.68% | 0.00% | 321,981 | -621,902 | -65.89% | 25,919,473 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.01% | 0.00% | 4,292 | -348,074 | -98.78% | 345,506 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.03% | 0.01% | 15,859 | -316,907 | -95.23% | 1,276,650 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -204,699 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | 0.00% | 16,276 | -203,822 | -92.61% | 1,310,000 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 1.09% | 0.68% | 516,533 | -168,943 | -24.65% | 41,580,907 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.22% | 0.00% | 102,645 | -142,882 | -58.19% | 8,262,923 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -138,300 | -100.00% | - | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 0.21% | 0.04% | 98,645 | -127,870 | -56.45% | 7,993,204 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.11% | 1.64% | 50,000 | -88,000 | -63.77% | 4,025,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -76,837 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -75,084 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.02% | 0.00% | 7,996 | -74,548 | -90.31% | 643,678 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.32% | 3.78% | 150,000 | -60,000 | -28.57% | 12,075,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.17% | 0.74% | 80,000 | -59,758 | -42.76% | 6,440,000 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.79% | 1.29% | 376,000 | -55,000 | -12.76% | 30,268,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.67% | 0.24% | 318,011 | -42,117 | -11.70% | 25,599,886 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.06% | 0.00% | 26,591 | -38,921 | -59.41% | 2,140,575 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -38,500 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Axsome Therapeutics's biggest institutional seller is PERCEPTIVE ADVISORS LLC. The company sold -0.65M shares of AXSM, valued at $36.96M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 0.85% | 0.00% | 404,217 | 404,217 | 100.00% | 32,539,469 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.84% | 1.86% | 400,000 | 400,000 | 100.00% | 32,200,000 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.65% | 1.30% | 310,198 | 310,198 | 100.00% | 24,970,939 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.63% | 1.80% | 300,000 | 300,000 | 100.00% | 24,150,000 | Jun 30, 2024 |
| SCOUT INVESTMENTS, INC. | 0.15% | 0.15% | 69,558 | 69,558 | 100.00% | 5,599,419 | Jun 30, 2024 |
| ABRDN PLC | 0.08% | 0.01% | 39,675 | 39,675 | 100.00% | 3,193,838 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.07% | 0.01% | 33,969 | 33,969 | 100.00% | 2,734,505 | Jun 30, 2024 |
| POINT72 EUROPE (LONDON) LLP | 0.06% | 0.20% | 30,741 | 30,741 | 100.00% | 2,474,610 | Jun 30, 2024 |
| STRATEGIC FINANCIAL CONCEPTS, LLC | 0.05% | 0.00% | 26,010 | 26,010 | 100.00% | 306,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.01% | 19,600 | 19,600 | 100.00% | 1,577,800 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.04% | 0.01% | 18,983 | 18,983 | 100.00% | 1,528,132 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 17,897 | 17,897 | 100.00% | 1,440,709 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.03% | 0.00% | 15,000 | 15,000 | 100.00% | 46,875 | Jun 30, 2024 |
| GREAT LAKES ADVISORS, LLC | 0.03% | 0.01% | 12,141 | 12,141 | 100.00% | 977,350 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.02% | 0.00% | 10,531 | 10,531 | 100.00% | 848,904 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.02% | 0.00% | 9,077 | 9,077 | 100.00% | 730,699 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 4,782 | 4,782 | 100.00% | 384,951 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.01% | 0.01% | 3,105 | 3,105 | 100.00% | 250,000 | Jun 30, 2024 |
| FLOWER CITY CAPITAL | 0.01% | 0.16% | 3,000 | 3,000 | 100.00% | 241,500 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.00% | 0.01% | 584 | 584 | 100.00% | 47,025 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 24,150 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 144 | 144 | 100.00% | 11,592 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 55 | 55 | 100.00% | 4,404 | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 47 | 47 | 100.00% | 3,784 | Jun 30, 2024 |
| STEPHENS CONSULTING, LLC | - | 0.00% | 20 | 20 | 100.00% | 1,610 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 12 | 12 | 100.00% | 966 | Jun 30, 2024 |
Axsome Therapeutics's largest new institutional shareholder by number of shares is NORGES BANK, purchased 404.22K shares, valued at $32.54M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -204,699 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -138,300 | -100.00% | - | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -76,837 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -75,084 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -38,500 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -36,816 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -36,607 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -35,461 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -33,417 | -100.00% | - | Jun 30, 2024 |
| CASTLEARK MANAGEMENT LLC | - | - | - | -32,200 | -100.00% | - | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -27,500 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -17,570 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -15,104 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -12,100 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -9,606 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -9,553 | -100.00% | - | Jun 30, 2024 |
| DAVENPORT & CO LLC | - | - | - | -5,817 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -4,869 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -4,733 | -100.00% | - | Jun 30, 2024 |
| HARMONY ASSET MANAGEMENT LLC | - | - | - | -4,537 | -100.00% | - | Jun 30, 2024 |
| SANDY SPRING BANK | - | - | - | -4,375 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -3,885 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -2,938 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -2,154 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,949 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -1,696 | -100.00% | - | Jun 30, 2024 |
| HANTZ FINANCIAL SERVICES, INC. | - | - | - | -1,100 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -102 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -60 | -100.00% | - | Jun 30, 2024 |
| LOWE WEALTH ADVISORS, LLC | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CAPITAL ADVISORY, LLC | - | - | - | -20 | -100.00% | - | Jun 30, 2024 |
| SYSTM WEALTH SOLUTIONS LLC | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Axsome Therapeutics's largest sold out institutional shareholder by shares sold is DRIEHAUS CAPITAL MANAGEMENT LLC, sold -0.20M shares, valued at -, as of undefined.
Axsome Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 1.21% | 198,366 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.13% | 435,377 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.06% | 283,454 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.05% | 108,461 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 26,106 | - | - | Mar 31, 2024 |
| Tema ETF Trust | 0.04% | 1,980 | 1,980 | - | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.04% | 25,141 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 291,300 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.03% | 30,527 | - | - | Jan 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.03% | 21,807 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.02% | 9,784 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.02% | 60,000 | 9,467 | 18.73% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.02% | 417 | 66 | 18.80% | Dec 31, 2023 |
| TOCQUEVILLE TRUST | 0.02% | 2,500 | - | - | Jan 31, 2024 |
| ROYCE CAPITAL FUND | 0.02% | 6,300 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.01% | 38,160 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.01% | 15,891 | 15,891 | - | Mar 28, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.01% | 4,775 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.01% | 16,941 | - | - | Feb 29, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.01% | 57,526 | 57,526 | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 18,038 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 40,819 | -29,320 | -41.80% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 62,941 | -1,124 | -1.75% | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.01% | 334,150 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,263 | -133 | -2.46% | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 90,352 | 1,600 | 1.80% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,287,310 | -548,030 | -14.29% | Mar 31, 2024 |
| Calvert Responsible Index Series, Inc. | 0.01% | 8,913 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.01% | 303,376 | 303,376 | - | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 43,090 | -10,244 | -19.21% | Mar 28, 2024 |
| VALUED ADVISERS TRUST | 0.00% | 4,392 | -578 | -11.63% | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 9,973 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 12,903 | 186 | 1.46% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 854 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 35,079 | 579 | 1.68% | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 218,103 | -48,300 | -18.13% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 4,452 | 690 | 18.34% | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 17,184 | -1,074 | -5.88% | Mar 31, 2020 |
| ALPS ETF Trust | 0.00% | 34,979 | 1,648 | 4.94% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 11,072 | 10,752 | 3360.00% | Dec 31, 2023 |
| Nushares ETF Trust | 0.00% | 18,952 | -394 | -2.04% | Jan 31, 2024 |
| FORUM FUNDS | 0.00% | 5,925 | - | - | Jan 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.00% | 75,013 | - | - | Mar 31, 2024 |
| WESMARK FUNDS | 0.00% | 8,300 | 8,300 | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 99,615 | 511 | 0.52% | Jan 31, 2024 |
| Securian Funds Trust | 0.00% | 23,618 | 23,618 | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 19,127 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 4,978 | -6,006 | -54.68% | Feb 29, 2024 |
| AMG Funds I | 0.00% | 4,420 | -1,714 | -27.94% | Jan 31, 2024 |
| ROYCE FUND | 0.00% | 13,000 | -500 | -3.70% | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 8,630 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 174,148 | -4,812 | -2.69% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 370,705 | 11,122 | 3.09% | Feb 29, 2024 |
| Ivy Variable Insurance Portfolios | 0.00% | 32,483 | 32,483 | - | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,690 | - | - | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 975 | -13 | -1.32% | Sep 30, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 1,557 | 1,537 | 7685.00% | Dec 31, 2023 |
| JPMORGAN INSURANCE TRUST | 0.00% | 16,381 | -719 | -4.20% | Mar 31, 2023 |
| HARTFORD SERIES FUND INC | 0.00% | 53,276 | 53,276 | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 11,865 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 4,651 | 4,549 | 4459.80% | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 41,620 | 7,042 | 20.37% | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 800 | - | - | Dec 31, 2023 |
| Guardian Variable Products Trust | 0.00% | 15,800 | 15,800 | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 76,673 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 10,490 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 23,583 | -1,832 | -7.21% | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 22,286 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.00% | 2,058 | - | - | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 18,176 | - | - | Dec 31, 2023 |
| OPTIMUM FUND TRUST | 0.00% | 27,954 | 430 | 1.56% | Mar 28, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 4,075 | - | - | Aug 31, 2023 |
| IVY FUNDS | 0.00% | 199,260 | 199,260 | - | Mar 28, 2024 |
| CARILLON SERIES TRUST | 0.00% | 33,096 | 33,096 | - | Mar 31, 2024 |
| ProFunds | 0.00% | 6,887 | 698 | 11.28% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 36,864 | -8,808 | -19.29% | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 11,366 | 212 | 1.90% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 111,493 | -5,965 | -5.08% | Feb 29, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 48,689 | 48,689 | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 228 | - | - | Apr 30, 2021 |
| Principal Exchange-Traded Funds | 0.00% | 4,982 | -409 | -7.59% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 5,007 | 147 | 3.02% | Mar 31, 2024 |
| Global X Funds | 0.00% | 16,781 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 11,762 | -2,354 | -16.68% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 204,212 | 7,487 | 3.81% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,674 | -68 | -3.90% | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 2,800 | - | - | Mar 28, 2024 |
| Investment Managers Series Trust II | 0.00% | 3,607 | 869 | 31.74% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,057 | - | - | Mar 28, 2024 |
| FundVantage Trust | 0.00% | 4,072 | - | - | Mar 28, 2024 |
| AMG FUNDS III | 0.00% | 1,357 | - | - | Mar 28, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 27,124 | 11,210 | 70.44% | Jan 31, 2024 |
| Virtus Strategy Trust | 0.00% | 5,478 | - | - | Mar 28, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 2,335 | 2,335 | - | Mar 28, 2024 |
| Voya INVESTORS TRUST | 0.00% | 13,443 | 2,485 | 22.68% | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 14,857 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 4,228 | 1,053 | 33.17% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 1,166 | - | - | Mar 31, 2024 |
| PUTNAM FUNDS TRUST | 0.00% | 42,700 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 533 | -33 | -5.83% | Mar 31, 2024 |
Axsome Therapeutics's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 198.37K shares, compromising 1.21% of its total assets.
Axsome Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 267 | -4.30% |
| 31 Mar, 24 | 279 | 6.90% |
| 31 Dec, 23 | 261 | 7.85% |
| 30 Sep, 23 | 242 | -3.59% |
| 30 Jun, 23 | 251 | 17.84% |
| 31 Mar, 23 | 213 | -11.98% |
| 31 Dec, 22 | 242 | 16.35% |
| 30 Sep, 22 | 208 | 7.22% |
| 30 Jun, 22 | 194 | 1.04% |
| 31 Mar, 22 | 192 | 2.13% |
| 31 Dec, 21 | 188 | -4.08% |
| 30 Sep, 21 | 196 | 1.55% |
| 30 Jun, 21 | 193 | -3.02% |
| 31 Mar, 21 | 199 | 0.51% |
| 31 Dec, 20 | 198 | 4.76% |
| 30 Sep, 20 | 189 | -9.13% |
| 30 Jun, 20 | 208 | 7.77% |
| 31 Mar, 20 | 193 | -2.03% |
| 31 Dec, 19 | 197 | 58.87% |
| 30 Sep, 19 | 124 | 5.08% |
| 30 Jun, 19 | 118 | 43.90% |
| 31 Mar, 19 | 82 | 115.79% |
| 31 Dec, 18 | 38 | 15.15% |
| 30 Sep, 18 | 33 | -10.81% |
| 30 Jun, 18 | 37 | 5.71% |
| 31 Mar, 18 | 35 | -2.78% |
| 31 Dec, 17 | 36 | 28.57% |
| 30 Sep, 17 | 28 | -17.65% |
| 30 Jun, 17 | 34 | -29.17% |
| 31 Mar, 17 | 48 | 17.07% |
| 31 Dec, 16 | 41 | 13.89% |
| 30 Sep, 16 | 36 | 2.86% |
| 30 Jun, 16 | 35 | 105.88% |
| 31 Mar, 16 | 17 | 54.55% |
| 31 Dec, 15 | 11 | - |
As of 30 Jun 24, 267 institutions are holding Axsome Therapeutics's shares, representing a decrease of -4.30% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 40,658,040 | 5.99% |
| 31 Mar, 24 | 38,358,702 | -0.55% |
| 31 Dec, 23 | 38,570,542 | 2.46% |
| 30 Sep, 23 | 37,643,354 | 3.53% |
| 30 Jun, 23 | 36,361,096 | 14.03% |
| 31 Mar, 23 | 31,887,082 | 6.15% |
| 31 Dec, 22 | 30,039,639 | 17.01% |
| 30 Sep, 22 | 25,672,407 | 19.01% |
| 30 Jun, 22 | 21,572,076 | 12.61% |
| 31 Mar, 22 | 19,156,141 | 2.94% |
| 31 Dec, 21 | 18,608,144 | -2.34% |
| 30 Sep, 21 | 19,054,376 | -14.83% |
| 30 Jun, 21 | 22,372,003 | -2.95% |
| 31 Mar, 21 | 23,053,139 | -3.80% |
| 31 Dec, 20 | 23,963,219 | -0.27% |
| 30 Sep, 20 | 24,028,005 | -0.86% |
| 30 Jun, 20 | 24,235,899 | 6.13% |
| 31 Mar, 20 | 22,837,001 | 2.06% |
| 31 Dec, 19 | 22,376,518 | 18.11% |
| 30 Sep, 19 | 18,945,378 | 3.21% |
| 30 Jun, 19 | 18,356,877 | 23.88% |
| 31 Mar, 19 | 14,817,945 | 287.22% |
| 31 Dec, 18 | 3,826,728 | 8.29% |
| 30 Sep, 18 | 3,533,773 | -13.88% |
| 30 Jun, 18 | 4,103,125 | -3.10% |
| 31 Mar, 18 | 4,234,297 | -27.28% |
| 31 Dec, 17 | 5,822,352 | -3.12% |
| 30 Sep, 17 | 6,009,619 | -6.16% |
| 30 Jun, 17 | 6,404,091 | -17.42% |
| 31 Mar, 17 | 7,754,937 | 25.74% |
| 31 Dec, 16 | 6,167,543 | -2.23% |
| 30 Sep, 16 | 6,308,291 | 8.77% |
| 30 Jun, 16 | 5,799,425 | 10.25% |
| 31 Mar, 16 | 5,260,385 | 0.83% |
| 31 Dec, 15 | 5,216,906 | - |
Axsome Therapeutics (AXSM) has 40.66M shares outstanding as of 30 Jun 24, up 5.99% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 85.79% | 1.20% |
| 31 Mar, 24 | 84.44% | 1.26% |
| 31 Dec, 23 | 81.86% | 1.10% |
| 30 Sep, 23 | 86.20% | 1.24% |
| 30 Jun, 23 | 83.54% | 1.56% |
| 31 Mar, 23 | 73.26% | 1.34% |
| 31 Dec, 22 | 73.89% | 1.95% |
| 30 Sep, 22 | 61.56% | 2.02% |
| 30 Jun, 22 | 55.20% | 2.21% |
| 31 Mar, 22 | 49.99% | 2.04% |
| 31 Dec, 21 | 49.47% | 1.93% |
| 30 Sep, 21 | 50.57% | 1.43% |
| 30 Jun, 21 | 59.51% | 1.57% |
| 31 Mar, 21 | 61.59% | 1.50% |
| 31 Dec, 20 | 64.16% | 1.55% |
| 30 Sep, 20 | 64.40% | 1.51% |
| 30 Jun, 20 | 65.32% | 1.72% |
| 31 Mar, 20 | 61.62% | 1.49% |
| 31 Dec, 19 | 64.38% | 2.13% |
| 30 Sep, 19 | 55.00% | 1.86% |
| 30 Jun, 19 | 54.31% | 2.70% |
| 31 Mar, 19 | 44.83% | 27.32% |
| 31 Dec, 18 | 12.81% | 7.11% |
| 30 Sep, 18 | 13.42% | 5.30% |
| 30 Jun, 18 | 15.91% | 5.77% |
| 31 Mar, 18 | 16.60% | 2.54% |
| 31 Dec, 17 | 25.58% | 3.96% |
| 30 Sep, 17 | 25.43% | 3.45% |
| 30 Jun, 17 | 27.14% | 1.72% |
| 31 Mar, 17 | 39.69% | 3.83% |
| 31 Dec, 16 | 32.20% | 2.97% |
| 30 Sep, 16 | 32.94% | 3.59% |
| 30 Jun, 16 | 30.29% | 4.01% |
| 31 Mar, 16 | 27.47% | 1.44% |
| 31 Dec, 15 | 43.67% | - |
As of 30 Jun 24, Axsome Therapeutics is held by 85.79% institutional shareholders, representing a 1.20% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 110 | -18.52% |
| 31 Mar, 24 | 135 | 20.54% |
| 31 Dec, 23 | 112 | 1.82% |
| 30 Sep, 23 | 110 | -23.08% |
| 30 Jun, 23 | 143 | 55.43% |
| 31 Mar, 23 | 92 | -25.81% |
| 31 Dec, 22 | 124 | 8.77% |
| 30 Sep, 22 | 114 | 17.53% |
| 30 Jun, 22 | 97 | 25.97% |
| 31 Mar, 22 | 77 | -3.75% |
| 31 Dec, 21 | 80 | -20.79% |
| 30 Sep, 21 | 101 | 8.60% |
| 30 Jun, 21 | 93 | -7.00% |
| 31 Mar, 21 | 100 | 16.28% |
| 31 Dec, 20 | 86 | 22.86% |
| 30 Sep, 20 | 70 | -45.31% |
| 30 Jun, 20 | 128 | 16.36% |
| 31 Mar, 20 | 110 | -4.35% |
| 31 Dec, 19 | 115 | 64.29% |
| 30 Sep, 19 | 70 | -17.65% |
| 30 Jun, 19 | 85 | 66.67% |
| 31 Mar, 19 | 51 | 200.00% |
| 31 Dec, 18 | 17 | 41.67% |
| 30 Sep, 18 | 12 | -7.69% |
| 30 Jun, 18 | 13 | -27.78% |
| 31 Mar, 18 | 18 | 20.00% |
| 31 Dec, 17 | 15 | 50.00% |
| 30 Sep, 17 | 10 | -28.57% |
| 30 Jun, 17 | 14 | -44.00% |
| 31 Mar, 17 | 25 | 25.00% |
| 31 Dec, 16 | 20 | 5.26% |
| 30 Sep, 16 | 19 | -29.63% |
| 30 Jun, 16 | 27 | 107.69% |
| 31 Mar, 16 | 13 | 18.18% |
| 31 Dec, 15 | 11 | - |
110 institutional shareholders have increased their position in AXSM stock as of 30 Jun 24 compared to 135 in the previous quarter (a -18.52% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 93 | 17.72% |
| 31 Mar, 24 | 79 | -11.24% |
| 31 Dec, 23 | 89 | 17.11% |
| 30 Sep, 23 | 76 | 38.18% |
| 30 Jun, 23 | 55 | -22.54% |
| 31 Mar, 23 | 71 | -1.39% |
| 31 Dec, 22 | 72 | 44.00% |
| 30 Sep, 22 | 50 | 4.17% |
| 30 Jun, 22 | 48 | -23.81% |
| 31 Mar, 22 | 63 | 18.87% |
| 31 Dec, 21 | 53 | 32.50% |
| 30 Sep, 21 | 40 | -16.67% |
| 30 Jun, 21 | 48 | -7.69% |
| 31 Mar, 21 | 52 | -17.46% |
| 31 Dec, 20 | 63 | -11.27% |
| 30 Sep, 20 | 71 | 54.35% |
| 30 Jun, 20 | 46 | 6.98% |
| 31 Mar, 20 | 43 | -15.69% |
| 31 Dec, 19 | 51 | 96.15% |
| 30 Sep, 19 | 26 | 44.44% |
| 30 Jun, 19 | 18 | 80.00% |
| 31 Mar, 19 | 10 | - |
| 31 Dec, 18 | 10 | 11.11% |
| 30 Sep, 18 | 9 | 28.57% |
| 30 Jun, 18 | 7 | - |
| 31 Mar, 18 | 7 | 16.67% |
| 31 Dec, 17 | 6 | -14.29% |
| 30 Sep, 17 | 7 | -41.67% |
| 30 Jun, 17 | 12 | 9.09% |
| 31 Mar, 17 | 11 | 83.33% |
| 31 Dec, 16 | 6 | -25.00% |
| 30 Sep, 16 | 8 | 33.33% |
| 30 Jun, 16 | 6 | 50.00% |
| 31 Mar, 16 | 4 | - |
| 31 Dec, 15 | - | - |
93 institutional shareholders have reduced their position in AXSM stock as of 30 Jun 24 compared to 79 in the previous quarter (a 17.72% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 267 | -4.30% | 40,658,040 | 5.99% | 85.79% | 1.20% | 110 | -18.52% | 93 | 17.72% |
| 31 Mar, 24 | 279 | 6.90% | 38,358,702 | -0.55% | 84.44% | 1.26% | 135 | 20.54% | 79 | -11.24% |
| 31 Dec, 23 | 261 | 7.85% | 38,570,542 | 2.46% | 81.86% | 1.10% | 112 | 1.82% | 89 | 17.11% |
| 30 Sep, 23 | 242 | -3.59% | 37,643,354 | 3.53% | 86.20% | 1.24% | 110 | -23.08% | 76 | 38.18% |
| 30 Jun, 23 | 251 | 17.84% | 36,361,096 | 14.03% | 83.54% | 1.56% | 143 | 55.43% | 55 | -22.54% |
| 31 Mar, 23 | 213 | -11.98% | 31,887,082 | 6.15% | 73.26% | 1.34% | 92 | -25.81% | 71 | -1.39% |
| 31 Dec, 22 | 242 | 16.35% | 30,039,639 | 17.01% | 73.89% | 1.95% | 124 | 8.77% | 72 | 44.00% |
| 30 Sep, 22 | 208 | 7.22% | 25,672,407 | 19.01% | 61.56% | 2.02% | 114 | 17.53% | 50 | 4.17% |
| 30 Jun, 22 | 194 | 1.04% | 21,572,076 | 12.61% | 55.20% | 2.21% | 97 | 25.97% | 48 | -23.81% |
| 31 Mar, 22 | 192 | 2.13% | 19,156,141 | 2.94% | 49.99% | 2.04% | 77 | -3.75% | 63 | 18.87% |
| 31 Dec, 21 | 188 | -4.08% | 18,608,144 | -2.34% | 49.47% | 1.93% | 80 | -20.79% | 53 | 32.50% |
| 30 Sep, 21 | 196 | 1.55% | 19,054,376 | -14.83% | 50.57% | 1.43% | 101 | 8.60% | 40 | -16.67% |
| 30 Jun, 21 | 193 | -3.02% | 22,372,003 | -2.95% | 59.51% | 1.57% | 93 | -7.00% | 48 | -7.69% |
| 31 Mar, 21 | 199 | 0.51% | 23,053,139 | -3.80% | 61.59% | 1.50% | 100 | 16.28% | 52 | -17.46% |
| 31 Dec, 20 | 198 | 4.76% | 23,963,219 | -0.27% | 64.16% | 1.55% | 86 | 22.86% | 63 | -11.27% |
| 30 Sep, 20 | 189 | -9.13% | 24,028,005 | -0.86% | 64.40% | 1.51% | 70 | -45.31% | 71 | 54.35% |
| 30 Jun, 20 | 208 | 7.77% | 24,235,899 | 6.13% | 65.32% | 1.72% | 128 | 16.36% | 46 | 6.98% |
| 31 Mar, 20 | 193 | -2.03% | 22,837,001 | 2.06% | 61.62% | 1.49% | 110 | -4.35% | 43 | -15.69% |
| 31 Dec, 19 | 197 | 58.87% | 22,376,518 | 18.11% | 64.38% | 2.13% | 115 | 64.29% | 51 | 96.15% |
| 30 Sep, 19 | 124 | 5.08% | 18,945,378 | 3.21% | 55.00% | 1.86% | 70 | -17.65% | 26 | 44.44% |
| 30 Jun, 19 | 118 | 43.90% | 18,356,877 | 23.88% | 54.31% | 2.70% | 85 | 66.67% | 18 | 80.00% |
| 31 Mar, 19 | 82 | 115.79% | 14,817,945 | 287.22% | 44.83% | 27.32% | 51 | 200.00% | 10 | - |
| 31 Dec, 18 | 38 | 15.15% | 3,826,728 | 8.29% | 12.81% | 7.11% | 17 | 41.67% | 10 | 11.11% |
| 30 Sep, 18 | 33 | -10.81% | 3,533,773 | -13.88% | 13.42% | 5.30% | 12 | -7.69% | 9 | 28.57% |
| 30 Jun, 18 | 37 | 5.71% | 4,103,125 | -3.10% | 15.91% | 5.77% | 13 | -27.78% | 7 | - |
| 31 Mar, 18 | 35 | -2.78% | 4,234,297 | -27.28% | 16.60% | 2.54% | 18 | 20.00% | 7 | 16.67% |
| 31 Dec, 17 | 36 | 28.57% | 5,822,352 | -3.12% | 25.58% | 3.96% | 15 | 50.00% | 6 | -14.29% |
| 30 Sep, 17 | 28 | -17.65% | 6,009,619 | -6.16% | 25.43% | 3.45% | 10 | -28.57% | 7 | -41.67% |
| 30 Jun, 17 | 34 | -29.17% | 6,404,091 | -17.42% | 27.14% | 1.72% | 14 | -44.00% | 12 | 9.09% |
| 31 Mar, 17 | 48 | 17.07% | 7,754,937 | 25.74% | 39.69% | 3.83% | 25 | 25.00% | 11 | 83.33% |
| 31 Dec, 16 | 41 | 13.89% | 6,167,543 | -2.23% | 32.20% | 2.97% | 20 | 5.26% | 6 | -25.00% |
| 30 Sep, 16 | 36 | 2.86% | 6,308,291 | 8.77% | 32.94% | 3.59% | 19 | -29.63% | 8 | 33.33% |
| 30 Jun, 16 | 35 | 105.88% | 5,799,425 | 10.25% | 30.29% | 4.01% | 27 | 107.69% | 6 | 50.00% |
| 31 Mar, 16 | 17 | 54.55% | 5,260,385 | 0.83% | 27.47% | 1.44% | 13 | 18.18% | 4 | - |
| 31 Dec, 15 | 11 | - | 5,216,906 | - | 43.67% | - | 11 | - | - | - |
Axsome Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Axsome Therapeutics's stock was made by Jacobson Mark L. on Aug 09 2024, selling 47,739 shares at $84.26 per share (valued at $4.02M).
Axsome Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 2 | 50.00% |
| Q2 2024 | 6 | 6 | 100.00% |
| Q1 2024 | 14 | 5 | 280.00% |
| Q4 2023 | 2 | - | - |
| Q3 2023 | 1 | 3 | 33.33% |
| Q2 2023 | 3 | - | - |
| Q1 2023 | 12 | 1 | 1200.00% |
| Q2 2022 | 4 | 3 | 133.33% |
| Q1 2022 | 7 | 1 | 700.00% |
| Q4 2021 | 13 | - | - |
| Q2 2021 | 4 | - | - |
| Q1 2021 | 9 | - | - |
| Q3 2020 | 1 | 1 | 100.00% |
| Q2 2020 | 5 | - | - |
| Q1 2020 | 19 | 13 | 146.15% |
| Q4 2019 | 3 | - | - |
| Q3 2019 | 5 | 3 | 166.67% |
| Q2 2019 | 9 | - | - |
| Q1 2019 | 8 | - | - |
| Q2 2018 | 8 | - | - |
1 total buy trades, and 2 total sell trades (buy/sell ratio of 0.50%) were made by Axsome Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 4 | - |
| Q1 2024 | - | 2 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 11 | - | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 2 | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 1 | - | - |
| Q2 2019 | 5 | - | - |
| Q1 2019 | 3 | - | - |
| Q2 2018 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Axsome Therapeutics's stocks.
Axsome Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| INCY | Incyte Corporation |
| AKRO | Akero Therapeutics, Inc. |
| TGTX | TG Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| SRPT | Sarepta Therapeutics, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| ACAD | ACADIA Pharmaceuticals Inc. |
| VKTX | Viking Therapeutics, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
AXSM Ownership FAQ
Who Owns Axsome Therapeutics?
Axsome Therapeutics is owned by institutional shareholders (85.79%), insiders (16.84%), and public (-2.63%). The largest institutional shareholder of Axsome Therapeutics is RTW INVESTMENTS, LP (9.78% of total shares) and the top mutual fund owner is Manager Directed Portfolios (1.21% of total shares).
Who are the major institutional shareholders of Axsome Therapeutics?
Axsome Therapeutics's major institutional shareholders are RTW INVESTMENTS, LP, VANGUARD GROUP INC, BLACKROCK INC., FAIRMOUNT FUNDS MANAGEMENT LLC, and DEEP TRACK CAPITAL, LP. The top five shareholders own together 33.53% of the company's share outstanding.
How many Axsome Therapeutics shareholders are there?
As of Jun 2024, there are 267 institutional shareholders of Axsome Therapeutics.
What percentage of Axsome Therapeutics is owned by RTW INVESTMENTS, LP?
RTW INVESTMENTS, LP owns 4.63M shares of Axsome Therapeutics, representing 9.78% of the company's total shares outstanding, valued at $373.06M (as of Jun 2024).
What percentage of Axsome Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 3.74M shares of Axsome Therapeutics (AXSM), compromising 7.90% of the company, valued at $301.23M.
What percentage of Axsome Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Axsome Therapeutics. The company owns 3.3M of the company's shares outstanding (worth $265.65M).